Asia Pacific Pharmaceutical Packaging Market

The Asia Pacific pharmaceutical packaging market is projected to grow from USD 52.15 billion in 2025 to USD 119.48 billion by 2030, at a CAGR of 18% during the forecast period.

The main trends driving the Asia Pacific pharmaceutical packaging market are the rapid growth of the pharmaceutical manufacturing sector, the rise in healthcare consumption, and the increasing exports of generic and specialty medicines. Besides, the production of injectables, vaccines, and biologics is rising, and with it the need for high-performance primary packaging, such as vials, prefilled syringes, and blister packs, that meet strict regulatory and quality requirements. Moreover, the continuous innovation of packaging materials such as lightweight plastics, barrier films, and smart packaging solutions, and the advanced manufacturing capabilities that these countries - China, India, Japan, and South Korea - possess are all supporting market growth and increasing adoption of the packaging trend in both domestic and export-oriented pharmaceutical industries. The key global players in the Asia Pacific pharmaceutical packaging market are Amcor plc (Switzerland), Gerresheimer AG (Germany), SCHOTT AG (Germany), Becton Dickinson & Co (US), WestRock Company (Ireland), AptarGroup, Inc (US), West Pharmaceutical Services, Inc (US), Parekhplast India Ltd. (India), Nipro Corporation (Japan), and SGD Pharma (France), among others. These companies are strong in their home regions and are exploring geographic diversification options to grow their businesses. They focus on increasing their market shares through new product launches and other expansions.

To know about the assumptions considered for the study download the pdf brochure

Amcor Plc (Switzerland)

Amcor plc is one of the top players in the area of packaging for pharmaceutical and healthcare products, and it provides different forms of packaging, blister packs, and sterile barrier systems, including in Asia Pacific. The company has a large regional manufacturing footprint that enables it to reach the top drug companies in China, India, Southeast Asia, and Australia. One of Amcor's most important advantages is its ability to provide packaging of the highest standard across the different stages of development, from the initial idea and material approval through to the finished product, including solid and injectable drugs in both high-barrier film and blister pack forms. The company's strategy in the Asia Pacific region is to establish additional local production sites, invest in advanced film and coating technologies, and increase customer proximity. Amcor, on the other hand, expands through selective acquisitions and capacity openings that provide both vertical integration and a wider range of healthcare packaging coverage.

Gerresheimer AG (Germany)

Gerresheimer AG is a major manufacturer of glass and plastic pharmaceutical packaging solutions, serving manufacturers of biotech, vaccines, and sterile drugs. The company's main areas of expertise are the production of high-quality glass vials, ampoules, and cartridges using both tubular and molded methods, and the provision of specialty plastic systems for injectable and biologic drugs, thereby ensuring product safety and regulatory compliance. Gerresheimer aims for regional growth through capacity expansions and partnerships with local converters and logistics providers, which will help to improve the reliability of the supply. Its strategy involves a phased approach, where the company invests in production facilities, upgrades technology, and relies on selective collaborations that create both vertical integration of manufacturing capabilities and horizontal expansion of the portfolio, thus consolidating its competitive position in the changing Asia Pacific pharmaceutical packaging market.

SCHOTT AG (Germany)

Schott AG is a significant manufacturer of top-quality pharmaceutical packaging and has a significant market share in Asia Pacific, from where it provides vials, ampoules, cartridges, and prefillable components for biologics, vaccines, and sterile drugs. The company is known for its advanced glass science, precision manufacturing, and strict compliance with international regulations. Schott's regional strategy is to add production capacity, upgrade technology, and consolidate pharmaceutical manufacturers and converters as partners to improve supply reliability. It is not only conducting capacity expansions but also entering into collaborative ventures to expand its product reach, which signifies both vertical integration into regional manufacturing operations and horizontal growth across multiple high-value primary packaging formats, thereby reinforcing its competitive position in the Asia Pacific pharmaceutical packaging market.

ASIA PACIFIC PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX

Through its extensive selection of flexible and rigid packaging, prefilled syringes, vials, and bottles, Amcor plc (Star) has secured a leading position in the Asia Pacific pharmaceutical packaging market. The company enjoys the most robust R&D capabilities, regulatory-compliant packaging solutions, and a vertically integrated manufacturing and distribution network, which respectively enable it to maintain a reliable supply and high-quality standards. Its strategic acquisitions, coupled with regional capacity expansions, further reinforce its market share. Nipro Corporation (Emerging Player) is steadily expanding in the area of specialty injectable and medical device packaging, at the same time cutting down its focus on precision manufacturing, patient-friendly prefilled systems, and temperature-controlled solutions. Nipro’s innovation, customization, and collaborations with local pharmaceutical companies are the strategies that help it emerge as a fast-developing player in the segment of high-value pharmaceutical packaging in Asia Pacific.

ASIA PACIFIC PHARMACEUTICAL PACKAGING MARKET: MARKET RANKING

The ranking of companies in the Asia Pacific pharmaceutical packaging market is based on several key factors that reflect their market position, capabilities, and overall contribution to the industry. The top 5 players in the Asia Pacific pharmaceutical packaging market have been identified based on their revenue, market share, product offerings, production capacity, innovation, technological advancements, geographical presence, strategic partnerships, financial performance, and sustainability efforts. These key players continue to lead the Asia Pacific pharmaceutical packaging market by maintaining a competitive edge through high-quality Pharmaceutical Packaging for various end-use industries. Major players operating in the market include Amcor plc (Switzerland), Gerresheimer AG (Germany), SCHOTT AG (Germany), Becton Dickinson & Co (US), WestRock Company (Ireland), AptarGroup, Inc (US), West Pharmaceutical Services, Inc (US), Parekhplast India Ltd. (India), Nipro Corporation (Japan), and SGD Pharma (France), among others.

Related Reports:

Asia Pacific Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery (Oral, Injectables, Topical), Packaging Type, Raw Material, And Country - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com